Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride

Clinica Chimica Acta; International Journal of Clinical Chemistry
Lei ZhangXingbo Cheng

Abstract

Asprosin has been identified as a novel hormone enriched in white adipose tissue and is pathologically increased in insulin-resistant mice and humans. However, information regarding the role of asprosin in type 2 diabetes mellitus (T2DM) remains unavailable. Via conducting a hospital-based study, we purposed to ascertain the potential relationship between circulating asprosin concentrations and T2DM. The study recruited 84 adults with T2DM and 86 controls with normal glucose tolerance. They matched in age, body mass index (BMI), and sex. Serum asprosin concentrations were measured via ELISA method. Compared to the controls, serum asprosin concentrations were significantly increased in the T2DM adults (P<0.001). As asprosin concentrations increased across its tertiles, the percentage of T2DM increased (39.28, 37.50, and 70.68%; P value for trend <0.001). Multivariate logistic regression models demonstrated that compared with the 1st tertile of asprosin, the odds ratio of T2DM was 3.278(95% CI 1.053-10.200, P=0.040) for the 3rd tertile after adjustment for potential confounders. Area under ROC curve of asprosin (sex and age adjusted) for predicting the presence of T2DM was 0.707[95% CI 0.628-0.786]. Finally, multiple stepwise reg...Continue Reading

Citations

Nov 22, 2018·International Journal of Obesity : Journal of the International Association for the Study of Obesity·Chao-Yung WangTa-Sen Yeh
Apr 25, 2019·Scientific Reports·Chia Lin ChangYung Kuei Soong
Feb 1, 2020·Pediatrics International : Official Journal of the Japan Pediatric Society·Eda Sünnetçi Silistre, Halil Uğur Hatipoğl
May 20, 2020·Archives of Physiology and Biochemistry·Halil İbrahim Ceylan, Özcan Saygın
Apr 13, 2020·Journal of Cell Communication and Signaling·Muthu L Muthu, Dieter P Reinhardt
Jul 2, 2020·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·Rulin DenizSuleyman Aydin
May 15, 2019·Journal of Clinical Medicine·Jeong Rim KoJin Han
Nov 19, 2019·Frontiers in Endocrinology·Jie ShiZhen Yang
Mar 22, 2020·Diabetes·Jennifer G HoffmannAtul R Chopra
Nov 7, 2019·Journal of Clinical Medicine·Won Kon KimKyoung-Jin Oh
Mar 11, 2020·Frontiers in Endocrinology·Mingyang YuanJing Wu
Feb 7, 2020·Eating and Weight Disorders : EWD·Yanran HuJue Chen
Jul 15, 2020·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Cheng DuZhendong Zheng
Sep 29, 2020·Frontiers in Physiology·Jung A Kim, Kyung Mook Choi
Jan 9, 2021·International Journal of Endocrinology·Xiaoan KeHuijuan Zhu
Dec 17, 2020·Porto Biomedical Journal·Carla LuísPedro von Hafe
Nov 24, 2020·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Xia DengGuoyue Yuan
Mar 6, 2021·Archives of Physiology and Biochemistry·Munevver Gizem HekimMete Ozcan
Mar 5, 2021·Cytokine·Domenico CoricaMalgorzata Wasniewska
Mar 23, 2021·International Journal of Endocrinology·Tao HongXin-Hua Xiao
May 3, 2021·Diabetology & Metabolic Syndrome·Rui WangWenchao Hu
Aug 10, 2021·World Journal of Pediatrics : WJP·Lu-Jie LiuYan-Feng Xiao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asprosin

Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.